4.7 Article

Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn

Mark Connors et al.

ANNALS OF INTERNAL MEDICINE (2021)

Article Computer Science, Artificial Intelligence

A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak

Xian-Xian Liu et al.

Summary: This paper proposes a nonlinear, self-adaptive dynamic coefficient infectious disease prediction model using neural networks, and simulates the effects of control measures and different strengths for the COVID-19 epidemic. The improved model is applied to the U.S. COVID-19 epidemic data, showing good agreement with the actual epidemic curve, and proves to have a higher level of prediction accuracy compared to traditional models.

APPLIED INTELLIGENCE (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Review Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis

Hayley A. Thompson et al.

Summary: Households have the highest transmission rates for SARS-CoV-2, especially when exposure exceeds 5 days. Asymptomatic cases have approximately one-seventh the transmission potential of symptomatic cases, while presymptomatic cases have approximately two-thirds.

CLINICAL INFECTIOUS DISEASES (2021)

Article Geriatrics & Gerontology

The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study

Francisco Javier Candel et al.

Summary: The study highlights the high prevalence of COVID-19 among residents in nursing homes, especially those who are frail and have comorbidities. Factors associated with seropositivity among staff include age, obesity, job type, workplace seroprevalence, and contact with external COVID-19 cases. Strengthening control measures is crucial to prevent COVID-19 transmission in care facilities.

AGE AND AGEING (2021)

Article Medicine, General & Internal

Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain

Victor Moreno-Torres et al.

Summary: Spain, particularly Madrid, was heavily impacted by COVID-19, with about 1752 patients admitted with suspected SARS-CoV-2 infection. The median age of hospitalized patients was 65 years, with a 13.8% mortality rate.

MEDICINE (2021)

Article Medicine, General & Internal

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman et al.

Summary: Despite evidence of vaccine efficacy, two fully vaccinated individuals developed mild symptoms of Covid-19 and were infected with variants of SARS-CoV-2. Sequencing of the virus isolates revealed novel mutations, highlighting the potential risk of illness post-vaccination and subsequent infection with variant virus. Efforts to prevent, diagnose, and characterize variants in vaccinated individuals are crucial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Virology

Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study

Sara Cruz Melguizo et al.

Summary: This study aimed to investigate the impact of maternal SARS-CoV-2 infection on perinatal outcomes, particularly preterm births. The findings revealed significant differences in preterm deliveries, premature rupture of membranes, venous thrombotic events, and incidence of severe pre-eclampsia between infected and uninfected pregnant women.

VIRUSES-BASEL (2021)

Article Immunology

Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination

Metodi Stankov et al.

Summary: The study shows that after a single dose of vaccine, the inhibition of SARS-CoV-2 variants by antibodies is weak and T-cell responses are low, with significant improvement only after the second dose. This calls into question the role of neutralizing antibodies in protecting against COVID-19 after a single vaccination, highlighting the importance of cellular immunity.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021

Elina Seppala et al.

Summary: This population-based cohort study found that the vaccine effectiveness against the Delta variant was significantly lower for partially vaccinated individuals at 22.4% compared to 64.6% for fully vaccinated individuals, when compared to vaccine effectiveness against the Alpha variant at 54.5% and 84.4% respectively.

EUROSURVEILLANCE (2021)

Article Infectious Diseases

Third wave of COVID-19 in Madrid, Spain

Vicente Soriano et al.

Summary: After Christmas 2020, Madrid experienced a third wave of COVID-19 with distinct features including household transmission, prompt diagnosis with rapid antigen tests, lower severity and mortality rates, increased presence of the more transmissible B.1.1.7 strain, vaccination benefits, and higher rates of reinfections. By Easter 2021, a quarter of the population in Madrid had been infected, highlighting the need for massive and accelerated vaccination campaigns to prevent further waves.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020

Julia Alcoba-Florez et al.

JOURNAL OF INFECTION (2021)

Article Multidisciplinary Sciences

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Zijun Wang et al.

Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.

NATURE (2021)

Article Infectious Diseases

Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

Maria Pilar Guallar et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Correction Biochemistry & Molecular Biology

Emerging Pandemic Diseases: How We Got to COVID-19 (vol 182, pg 1077, 2020)

David M. Morens et al.